Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1.

Ruiz de Almodovar C, Coulon C, Salin PA, Knevels E, Chounlamountri N, Poesen K, Hermans K, Lambrechts D, Van Geyte K, Dhondt J, Dresselaers T, Renaud J, Aragones J, Zacchigna S, Geudens I, Gall D, Stroobants S, Mutin M, Dassonville K, Storkebaum E, Jordan BF, Eriksson U, Moons L, D'Hooge R, Haigh JJ, Belin MF, Schiffmann S, Van Hecke P, Gallez B, Vinckier S, Chédotal A, Honnorat J, Thomasset N, Carmeliet P, Meissirel C.

J Neurosci. 2010 Nov 10;30(45):15052-66. doi: 10.1523/JNEUROSCI.0477-10.2010.

2.

Enhancement of vascular progenitor potential by protein kinase A through dual induction of Flk-1 and Neuropilin-1.

Yamamizu K, Kawasaki K, Katayama S, Watabe T, Yamashita JK.

Blood. 2009 Oct 22;114(17):3707-16. doi: 10.1182/blood-2008-12-195750. Epub 2009 Aug 25.

3.

Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.

Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, Bodary SC, Hodivala-Dilke KM.

Cancer Res. 2004 Dec 1;64(23):8643-50.

4.

EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2.

Bougatef F, Quemener C, Kellouche S, Naïmi B, Podgorniak MP, Millot G, Gabison EE, Calvo F, Dosquet C, Lebbé C, Menashi S, Mourah S.

Blood. 2009 Dec 24;114(27):5547-56. doi: 10.1182/blood-2009-04-217380. Epub 2009 Oct 16.

5.

Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.

Stalmans I.

Verh K Acad Geneeskd Belg. 2005;67(4):229-76. Review.

PMID:
16334858
6.

Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.

Gebhardt M, Mentlein R, Schaudig U, Pufe T, Recker K, Nölle B, Al-Samir K, Geerling G, Paulsen FP.

Ophthalmology. 2005 Jun;112(6):1023-30.

PMID:
15885787
7.

Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.

Hervé MA, Meduri G, Petit FG, Domet TS, Lazennec G, Mourah S, Perrot-Applanat M.

J Endocrinol. 2006 Jan;188(1):91-9.

PMID:
16394178
8.

Vascular endothelial growth factor directly inhibits primitive neural stem cell survival but promotes definitive neural stem cell survival.

Wada T, Haigh JJ, Ema M, Hitoshi S, Chaddah R, Rossant J, Nagy A, van der Kooy D.

J Neurosci. 2006 Jun 21;26(25):6803-12.

9.

Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2).

Gonzalez RR, Cherfils S, Escobar M, Yoo JH, Carino C, Styer AK, Sullivan BT, Sakamoto H, Olawaiye A, Serikawa T, Lynch MP, Rueda BR.

J Biol Chem. 2006 Sep 8;281(36):26320-8. Epub 2006 Jul 6.

10.

Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice.

Amano K, Okigaki M, Adachi Y, Fujiyama S, Mori Y, Kosaki A, Iwasaka T, Matsubara H.

J Mol Cell Cardiol. 2004 Apr;36(4):469-80.

PMID:
15081307
11.

Captopril and vascular endothelial growth factor in a mouse model of retinopathy.

Higgins RD, Yan Y, Geng Y, Sharma J, Barr SM.

Curr Eye Res. 2003 Aug;27(2):123-9.

PMID:
14632165
12.

Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.

Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T.

Circ Res. 2003 Sep 5;93(5):438-47. Epub 2003 Jul 24.

PMID:
12881481
13.

EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.

Seeliger H, Camaj P, Ischenko I, Kleespies A, De Toni EN, Thieme SE, Blum H, Assmann G, Jauch KW, Bruns CJ.

Mol Cancer Res. 2009 Feb;7(2):189-98. doi: 10.1158/1541-7786.MCR-08-0132. Epub 2009 Feb 10.

14.

Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.

Yasuhara T, Shingo T, Kobayashi K, Takeuchi A, Yano A, Muraoka K, Matsui T, Miyoshi Y, Hamada H, Date I.

Eur J Neurosci. 2004 Mar;19(6):1494-504.

PMID:
15066146
15.

Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis.

Vlahakis NE, Young BA, Atakilit A, Hawkridge AE, Issaka RB, Boudreau N, Sheppard D.

J Biol Chem. 2007 May 18;282(20):15187-96. Epub 2007 Mar 14.

16.

Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.

Ritter E, Perry A, Yu J, Wang T, Tang L, Bieberich E.

Ann Surg. 2008 Feb;247(2):310-4. doi: 10.1097/SLA.0b013e31816401d5.

PMID:
18216538
17.

The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model.

Pufe T, Scholz-Ahrens KE, Franke AT, Petersen W, Mentlein R, Varoga D, Tillmann B, Schrezenmeir J, Glüer CC.

Bone. 2003 Dec;33(6):869-76.

PMID:
14678846
18.

Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.

Oh H, Takagi H, Otani A, Koyama S, Kemmochi S, Uemura A, Honda Y.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):383-8. Epub 2001 Dec 26.

19.

[Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].

Chen XL, Liu LC, Xu ZG, Li Z, Li RW, Gao RJ, Wang S, Zhang M, Guo H.

Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):578-82. Chinese.

PMID:
19102933
20.

Induction of angiogenesis by expression of soluble type II transforming growth factor-beta receptor in mouse hepatoma.

Kim KY, Jeong SY, Won J, Ryu PD, Nam MJ.

J Biol Chem. 2001 Oct 19;276(42):38781-6. Epub 2001 Jul 16.

Supplemental Content

Support Center